Drug Shortage Report for ELTROXIN
| Report ID | 246460 |
| Drug Identification Number | 02213206 |
| Brand name | ELTROXIN |
| Common or Proper name | levothyroxine sodium |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOTHYROXINE SODIUM |
| Strength(s) | 100MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 500 Tablet |
| ATC code | H03AA |
| ATC description | THYROID PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-18 |
| Estimated end date | 2025-05-31 |
| Actual end date | 2025-04-07 |
| Shortage status | Resolved |
| Updated date | 2025-04-08 |
| Company comments | GR10011CA1 ELTROXIN 100MCG TAB BOT 500 CA ASP |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-04-08 | English | Compare |
| v6 | 2025-04-04 | French | Compare |
| v5 | 2025-04-04 | English | Compare |
| v4 | 2025-01-08 | French | Compare |
| v3 | 2025-01-08 | English | Compare |
| v2 | 2024-12-24 | French | Compare |
| v1 | 2024-12-24 | English | Compare |
Showing 1 to 7 of 7